Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab [Phase 2]
Phase 2 trial assessing atezolizumab/bevacizumab followed by on-demand TACE or initial synchronous TACE with atezolizumab/bevacizumab for un…
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Multi-analyte Blood Test Clinical Trial
This clinical trial update notes that a multi-analyte blood test is currently recruiting for evaluation in patients with cirrhosis and hepat…
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma
A clinical trial status update indicating recruitment for a study combining TACE, TKIs/anti-VEGF therapy, and immune checkpoint inhibitors a…
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
A pediatric trial evaluating Yttrium-90 radioembolization for liver tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: Cost-effectiveness of RFA vs. PEI for Early-stage HCC [NA]
A completed trial compares the cost-effectiveness of radiofrequency ablation versus percutaneous ethanol injection for early-stage hepatocel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 study evaluating transarterial chemoembolization combined with tyrosine kinase inhibitors and tislelizumab in unresectable hepatocel…
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma
A ClinicalTrials.gov entry for a study evaluating whether ctDNA-MRD and microvascular invasion can more accurately predict postoperative rec…
-
CLINICAL_TRIALS trial_result · 2024-06-05Clinical Trial Update: Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC) [Phase 2]
A Phase 2 trial evaluating atezolizumab and bevacizumab with Y-90 radioembolization for unresectable hepatocellular carcinoma was terminated…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease. [Phase 3]
Phase 3 trial update announcing a study to evaluate zinc supplementation for improving prognosis in patients with compensated advanced chron…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Liver Cancer Disparities in American Indian and Alaska Native Persons [Phase 2]
This clinical trial update discusses a Phase 2 study investigating liver cancer disparities affecting American Indian and Alaska Native peop…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma [NA]
Completed trial comparing transarterial chemoembolization versus proton beam radiotherapy for hepatocellular carcinoma; results have been po…
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation
A clinical trial is recruiting to test Huaier Granule for preventing recurrence and metastasis of hepatocellular carcinoma after local ablat…
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: Comparison of Gd-EOB-DTPA-enhanced MRI and Contrast-enhanced Ultrasound for Measuring Tumor Size of Solitary Hepatocellular Carcinoma ≤ 5cm:A Retrospective Study
A retrospective study comparing Gd-EOB-DTPA-enhanced MRI and contrast-enhanced ultrasound for measuring the size of solitary hepatocellular …
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: A Study of the Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 study evaluating the combination of AK105 (anti-PD-1) and Anlotinib for first-line hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC
A completed clinical trial comparing lenvatinib versus bevacizumab plus immune checkpoint inhibitors and HAIC in unresectable hepatocellular…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports results for the combination of sorafenib tosylate and pembrolizumab in advanced or metastatic hepa…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma [Phase 3]
Phase 3 clinical trial evaluating postoperative transarterial chemoembolization for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS safety_alert · 2024-05-29Clinical Trial Update: Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients
This post-marketing surveillance update assesses the safety of Cabometyx in Korean patients with Renal Cell Carcinoma, Hepatocellular Carcin…
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: cTACE Plus Sintilimab for Unresectable Intermediate-stage HCC With Beyond Up-to-seven Criteria [Phase 2]
Phase 2 study evaluating cTACE plus sintilimab for unresectable intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria has …
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery [Phase 1]
Phase 1 clinical trial update for ITGA6-targeted NIR-II fluorescence image-guided surgery in hepatocellular carcinoma, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: An Intraoperative Guidance Platform for Radio Frequency Ablation [NA]
A completed clinical trial evaluated an intraoperative guidance platform to assist radiofrequency ablation for hepatocellular carcinoma, wit…
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7
This clinical trial update describes a study evaluating PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy, with or without transar…
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: The Dual Impact of Cirrhosis on Transplantation for Hepatocellular Carcinoma：a Two-center Retrospective Cohort Study in China
A two-center retrospective cohort study from China examining how cirrhosis affects liver transplantation outcomes for hepatocellular carcino…
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Vienna Hypothermic Oxygenated Machine Perfusion Study
A clinical trial update from the Medical University of Vienna describes a study on hypothermic oxygenated machine perfusion for liver condit…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Postoperative Symptoms in Chinese Liver Cancer Patients: Network Analysis
This clinical trial evaluated postoperative symptoms in hepatocellular carcinoma patients undergoing curative liver surgery using network an…